28,490 resources
By Version
By Authority
By Realm
Start Prev Rows 1000 - 1200 Next
Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Auth | Source(s) |
---|---|---|---|---|---|---|---|---|---|---|
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.649 | Psychosis (ICD10 and SNOMED) | active | 2023-10 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.650 | Cluster Headache (SNOMED) | active | 2023-12 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.651 | Galcanezumab (RxNorm) | active | 2023-12 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.652 | Lithium (RxNorm) | active | 2023-12 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.653 | Verapamil | active | 2023-12 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.654 | Long term preventive medications for cluster headache | active | 2023-12 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.655 | Short term preventive medication for cluster headache | active | 2023-12 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.656 | Zolmitriptan | active | 2023-12 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.657 | Sumatriptan | active | 2023-12 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.658 | Dihydroergotamine | active | 2023-12 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.659 | Acute cluster headache medication | active | 2023-12 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.660 | Acute cluster headache treatment | active | 2023-12 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.661 | Short term preventive treatment for cluster headache | active | 2023-12 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.662 | Long term preventive treatment for cluster headache | active | 2023-12 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.663 | Migraine diagnosis (ICD) | active | 2025-05 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.664 | Prescribable NSAIDs and Acute Migraine Attack Medication | active | 2025-05 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.103 | Abnormal Presentation | active | 2023-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.105 | Abnormal Presentation | active | 2021-06 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.130 | Respiratory Rate | active | 2023-02 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.15 | Intravenous Thrombolytic tPA Therapy | active | 2021-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.16 | Intraarterial Thrombolytic tPA Therapy | active | 2021-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.163 | Systolic Blood Pressure | active | 2023-02 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.171 | Abnormal Presentation | active | 2024-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.173 | Delivery of Singleton | active | 2021-06 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.21 | Intravenous or Intraarterial Thrombolytic tPA Therapy | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.26 | Estimated Gestational Age at Delivery | active | 2021-06 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.27 | Cornual Ectopic Pregnancy | active | 2021-06 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.38 | General Or Neuraxial Anesthesia | active | 2021-02 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.39 | Low Dose Unfractionated Heparin for VTE Prophylaxis | active | 2024-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.41 | Glycoprotein IIb IIIa Inhibitors | active | 2023-01 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.55 | Oxytocin | active | 2021-06 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.56 | Dinoprostone | active | 2025-05 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.58 | Delivery Procedures | active | 2021-06 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.59 | Delivery Procedures | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.67 | PCI | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.68 | Endotracheal Intubation | active | 2018-03 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.69 | Endotracheal Intubation | active | 2025-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.98 | Delivery of Singleton | active | 2021-06 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.99 | Delivery of Singleton | active | 2021-06 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1046.225 | Opioid Medication Assisted Treatment (MAT) SNOMED | active | 2024-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1046.241 | Schedule II, III and IV Opioid Medications | active | 2024-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1046.242 | Opioid Use Disorder | active | 2024-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1046.243 | Opioid Use Disorder | active | 2024-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1046.265 | Inpatient, Emergency, and Observation Locations | active | 2022-07 | us | hl7 | cdc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1046.269 | Medications for Opioid Use Disorder (MOUD) | active | 2024-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1046.274 | NHSN Inpatient Encounter Class Codes | active | 2024-04 | us | hl7 | tho | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1046.277 | Emergency Department Location | active | 2024-04 | us | hl7 | cdc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1046.278 | Emergency Department Treatment Location | active | 2025-02 | us | hl7 | cdc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1046.283 | Emergency Department Location | active | 2024-04 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1046.284 | Emergency Department Location | active | 2024-09 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1046.285 | Mental Health Diagnosis without Substance Use Disorders | active | 2024-09 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1046.286 | Decision to Transfer | active | 2024-07 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1046.35 | Healthcare Agent or Proxy Choices | active | 2022-10 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.10 | Breastfeeding | active | 2025-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.100 | Familial Hypercholesterolemia | active | 2021-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.102 | Rhabdomyolysis | active | 2017-05 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.107 | Low Intensity Statin Therapy | active | 2025-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.12 | Liver Disease | active | 2025-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.13 | Rhabdomyolysis | active | 2025-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.19 | Atherosclerosis and Peripheral Arterial Disease | active | 2025-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.20 | Atherosclerosis and Peripheral Arterial Disease | active | 2025-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.21 | Atherosclerosis and Peripheral Arterial Disease | active | 2024-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.22 | Liver Disease ICD9 | active | 2024-06 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.37 | Stable and Unstable Angina | active | 2025-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.39 | Cerebrovascular Disease Stroke or TIA | active | 2023-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.41 | Ischemic Heart Disease or Related Diagnoses | active | 2025-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.42 | Liver Disease | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.43 | Liver Disease | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.44 | Cerebrovascular Disease Stroke or TIA | active | 2024-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.46 | Ischemic Heart Disease or Related Diagnoses | active | 2024-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.47 | Stable and Unstable Angina | active | 2024-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.501 | Overweight or Obese | active | 2025-01 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.502 | Overweight or Obese | active | 2018-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.512 | Elevated Blood Pressure Reading | active | 2019-03 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.513 | Elevated Blood Pressure Reading | active | 2020-03 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.514 | Finding of Elevated Blood Pressure or Hypertension | active | 2019-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.515 | Bariatric Procedures | active | 2024-02 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.517 | Age related macular degeneration intermediate dry | active | 2024-06 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.518 | Ophthalmologist visit | active | 2024-06 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.519 | Posterior vitreous detachment (PVD) | active | 2024-06 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.521 | Ophthalmoscopic exam | active | 2024-06 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.523 | Opthalmoscopic exams with Scleral Depression | active | 2024-06 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.525 | Referral (ophthalmology) | active | 2024-06 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.526 | Retina Ultrasound | active | 2024-06 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.527 | Retina visualization inadequate | active | 2024-06 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.528 | Refusal or Noncompliance with treatment | active | 2024-06 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.529 | Vitreous hemorrhage | active | 2024-06 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.530 | Vitreous hemorrhage | active | 2024-06 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.536 | Macula examination | active | 2024-06 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.539 | Fluorescein angiography | active | 2024-06 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.541 | Optical coherence tomography (OCT) | active | 2024-06 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.542 | Intravitreal injection | active | 2024-06 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.543 | Bevacizumab injection | active | 2024-06 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.544 | Ranibizumab injection | active | 2024-06 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.545 | Aflibercept injection | active | 2024-06 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.552 | Uveitis | active | 2024-06 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.553 | Uveitis | active | 2024-06 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.554 | Post Cataract Surgery Cystoid Macular Edema AND Idiopathic Macular Edema | active | 2024-06 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.555 | Macular edema | active | 2024-06 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.556 | Corticosteroids for Injection | active | 2024-06 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.557 | Corticosteroids for Injection | active | 2024-06 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.560 | Tonometry | active | 2024-06 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.561 | Intraocular pressure | active | 2024-06 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.571 | Retinal Vein Occlusion Related Macular Edema | active | 2024-06 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.576 | Vitreous hemorrhage | active | 2020-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.580 | Intravitreal and Periocular Injections | active | 2020-03 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.581 | Intravitreal and Periocular Injections | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.582 | Corticosteroids for Injection | active | 2020-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.583 | Endophthalmitis in the Right Eye | active | 2020-03 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.584 | Endophthalmitis in the Left Eye | active | 2020-03 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.585 | Panophthalmitis in the Right Eye | active | 2020-03 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.586 | Panophthalmitis in the Left Eye | active | 2020-03 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.587 | Lost to follow up | active | 2020-03 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.588 | Uveitis | active | 2020-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.610 | Scleral depressed exam | active | 2020-03 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.611 | 3 Mirror Goldmann exam | active | 2020-03 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.612 | Scleral depressed exam | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.615 | Physical Disability | active | 2020-03 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.616 | Financial difficulty | active | 2020-03 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.617 | Vitreous exam findings | active | 2020-03 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.619 | Scleral depressed exam | active | 2020-03 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.629 | Post operative follow up | active | 2020-07 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.67 | Breastfeeding | active | 2017-05 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.69 | Stable and Unstable Angina | active | 2025-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.70 | Ischemic Heart Disease or Related Diagnoses | active | 2021-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.71 | Cerebrovascular Disease Stroke or TIA | active | 2023-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.73 | Breastfeeding | active | 2021-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.85 | Familial Hypercholesterolemia | active | 2023-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.89 | Rhabdomyolysis | active | 2017-05 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.9 | Outpatient Encounters for Preventive Care | active | 2019-03 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.91 | Familial Hypercholesterolemia | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.93 | Hypercholesterolemia ICD 9 | active | 2024-06 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.97 | High Intensity Statin Therapy | active | 2024-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.98 | Moderate Intensity Statin Therapy | active | 2025-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1056.50 | HIV Lab Tests | active | 2025-02 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1056.51 | Indicators of Human Immunodeficiency Virus (HIV) | active | 2024-06 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1056.52 | Indicators of Human Immunodeficiency Virus (HIV) | active | 2024-06 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1056.53 | Indicators of Human Immunodeficiency Virus (HIV) | active | 2024-06 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1056.71 | Human Immunodeficiency Virus (HIV) Viral Load | active | 2024-06 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.10 | ARBs (Angiotensin Receptor Blockers) | active | 2024-12 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1000 | OIA_V2_GLP1s_RxNorms | active | 2025-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1001 | OIA_V2_PCSK9s_RxNorms | active | 2025-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1002 | OIA_RFs_Secondary_Prevention_ICD10 | active | 2025-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1003 | OIA_RFs_Secondary_Prevention_SNOMED | active | 2025-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1004 | OIA_RFs_Secondary_Prevention_CPT | active | 2025-02 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1005 | OIA_RFs_Secondary_Prevention_ICD_SM_CPT | active | 2025-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1006 | OIA_Asthma_COPD_Combo_Meds | active | 2025-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1007 | OIA_Asthma_COPD_Combo_Meds_SABA_SAMA | active | 2025-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1008 | OIA_Asthma_COPD_Combo_Meds_LABA_LAMA_ICS | active | 2025-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1009 | PAE_Patient_Conditions | active | 2025-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1012 | PAE Conditions Short | active | 2025-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1016 | OIA_TEST_VS | active | 2025-03 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1017 | Triptan Allergy NDFRT | active | 2025-04 | us | hl7 | fhir | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1018 | NSAID Allergy NDFRT | active | 2025-04 | us | hl7 | fhir | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1019 | Statin Allergy NDFRT | active | 2025-04 | us | hl7 | fhir | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1021 | Penicillin Allergy NDFRT | active | 2025-04 | us | hl7 | fhir | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1022 | Macrolide Allergy NDFRT | active | 2025-04 | us | hl7 | fhir | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1023 | Quinolone Allergy NDFRT | active | 2025-04 | us | hl7 | fhir | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1025 | Beta blocker Allergy NDFRT | active | 2025-04 | us | hl7 | fhir | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1026 | ACE inhibitor Allergy NDFRT | active | 2025-04 | us | hl7 | fhir | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1027 | ARB Allergy NDFRT | active | 2025-04 | us | hl7 | fhir | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1028 | Sulfonylurea Allergy NDFRT | active | 2025-04 | us | hl7 | fhir | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1030 | DPP4i Allergy NDFRT | active | 2025-04 | us | hl7 | fhir | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1031 | GLP1RA Allergy NDFRT | active | 2025-04 | us | hl7 | fhir | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1032 | Beta blocker allergy intolerance | active | 2025-04 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1033 | SGLT2i Allergy NDFRT | active | 2025-04 | us | hl7 | fhir | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1034 | MRA Allergy NDFRT | active | 2025-04 | us | hl7 | fhir | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1036 | Meglitinide Allergy NDFRT | active | 2025-04 | us | hl7 | fhir | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1037 | Alpha glucosidase inhibitor Allergy NDFRT | active | 2025-04 | us | hl7 | fhir | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1038 | TZD Allergy NDFRT | active | 2025-04 | us | hl7 | fhir | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1041 | Hemoglobin | active | 2025-05 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1042 | Hematocrit | active | 2025-05 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1043 | Anemia for Erythropoesis Simulating Agents I10 | active | 2025-05 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1044 | Anemia for Erythropoesis Simulating Agents SCT | active | 2025-05 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1045 | Anemia for Erythropoesis Simulating Agents | active | 2025-05 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1046 | AZT Meds | active | 2025-05 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1047 | Ferritin | active | 2025-05 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1048 | Knee pain I10 | active | 2025-05 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1049 | Knee pain SCT | active | 2025-05 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.105 | conditions_heartfailure | active | 2023-07 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1050 | Knee pain | active | 2025-05 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1051 | Knee decreased ROM SCT | active | 2025-05 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1052 | Knee effusion I10 | active | 2025-05 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1054 | Knee effusion | active | 2025-05 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1055 | Knee crepitus SCT | active | 2025-05 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1056 | OIA_Antiemetics | active | 2025-05 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1057 | OIA_PDE5is | active | 2025-05 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1058 | OIA_Vitamins | active | 2025-05 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1059 | OIA_Plavix | active | 2025-05 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1061 | OIA_Oral_Contraceptives | active | 2025-05 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1063 | OIA_Topical_Steroids | active | 2025-05 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1064 | OIA_Cough_Cold_Meds | active | 2025-05 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1065 | Antiperspirant aluminum salts | active | 2025-05 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1066 | Antiperspirant anticholinergics | active | 2025-05 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1067 | Antieplieptic medications | active | 2025-05 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1068 | Antidepressant medications | active | 2025-05 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1069 | Urinary incontinence SCT | active | 2025-05 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1070 | Urinary incontinence I10 | active | 2025-05 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1071 | Urinary incontinence | active | 2025-05 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1073 | Hemifacial spasm SCT | active | 2025-05 | us | hl7 | sct |